Fundraising FoxOrthoBio Therapeutics
Vail, US · Delaware corporation
Find your way into OrthoBio Therapeutics
Sign up to see every warm intro you have to OrthoBio Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the OrthoBio Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
MP
Marc PrisantExecutive
PJ
Peter J. MillettNamed on SEC filing
Board
SS
Stanley ShumanBoard director
JH
Jessica HopfieldBoard director
LD
Lodewijk de VinkBoard director
WT
William T. EsreyBoard director
RH
Robert HuginBoard director
Reported raises · per SEC filings
Form D private placements$31.4M disclosed across 1 round · 2025
▶$31.4MraisedJul 2025 · 45 investors · BiotechnologyRule 506(b)
▶$31.4MraisedJul 2025 · 45 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jessica HopfieldDirector
- Stanley ShumanDirector
- Marc PrisantExecutive Officer
- Peter J. MillettExecutive Officer, Director
- Lodewijk de VinkDirector
- William T. EsreyDirector
- Robert HuginDirector
- Offering amount
- $31.4M
- Amount sold
- $31.4M
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has OrthoBio Therapeutics raised?
- OrthoBio Therapeutics has disclosed $31.4M raised across 1 round.
- Where is OrthoBio Therapeutics headquartered?
- OrthoBio Therapeutics is headquartered in Vail, US.